Congratulations to Omar Alhalabi, MD for the Humanitas award @CancerMedMDA Hem/Onc graduation 2020 🥇!!! Following our amazing previous Humanitas awardees Pavlos Msaouel @DrJasonWillis !!!

Congratulations to Jeffrey Ravetch, MD, Ph.D. of Rockefeller University, winner of the 2020 Bladder Cancer Research Innovation Award given to novel and creative projects with great potential to produce breakthroughs in the management of bladder cancer. bcan.org/2020-bladder-c…

Excited to finally see this project in print- efforts of many generations of MD Anderson Cancer Center Society of Urologic Oncology Dinney/McConkey fellows and collaborators! Grateful to have been a part of it Sima Porten @urodocLim Isuru Jayaratna MD Neema Navai David McConkey Bradley Broom Molecular Cancer Research mcr.aacrjournals.org/content/early/…

One of my pet peeves is receiving difficult cases for consultation without a block sent. I teach my fellows that wind up in private practice, that if it is tough for the referring pathologist, it will prob be tough for me! Sending the block up front prevents delays.#PathTwitter

Southern Oregon is in full bloom as #asante Urology (Liam C. Macleod, Dr. Jim Loos, Christina Martin, DNP) and OHSU Urology Sudhir Isharwal walk for bladder cancer awareness month Bladder Cancer Advocacy Network #bcanwalk2021.

Seeking research assistant to study bladder cancer immunology. Studying sex bias. Molecular biology, mouse models, clinical samples, biomarker development. Pelotonia Zihai Li, MD, PhD William E. Carson III If you know of someone or if you are that someone message me & let's talk! The James at Ohio State

Embracing the rural healthy lifestyle prerounds run Roxy Ann peak with the Medford Uro Oncs ⁦@urodocLim⁩ and Christina Martin - run/rounds and home to kids/Fam by 8am = winning

Great to see #bladdercancer formally recognized as a presumptive condition related to Agent Orange exposure by Veterans Affairs-super important for Veterans. We looked at this link in our pts Minneapolis VA Health Care System w/ Mike Risk Philipp Dahm, & Cesar Ercole Bladder Cancer Advocacy Network Amer. Urol. Assn.

You guys are the best team🥰. Can’t wait until the video of the concert is posted on anniemacleodmusic.com.

The #Oregon Nurses Association has released a statement regarding the new vaccine mandate that is now law. #ForTheValley medfordalert.com/2021/08/26/sta…

Join us in congratulating Roger Li of Moffitt Cancer Center for being the first-ever awardee of BCAN's Career Development Award (CDA). The CDA is a 3-year, $250,000 grant to support translational, clinical or epidemiological #bladdercancer research. Read more: bcan.org/bcan-announces…

FDA grants accelerated approval to EV+Pembro for patients with locally advanced or metastatic #bladdercancer ineligible for cisplatin-chemo Congrats to entire team: Christopher Hoimes Shilpa Gupta Thomas Flaig Rana McKay, MD, FASCO Jonathan Rosenberg MD + patients! Bladder Cancer Advocacy Network IBCG

As promised here is our published prostate randomized oligomet trial. Neil Desai Vedang Murthy Piet Ost Alfonso Gomez-Iturriaga Dr. Andrew Loblaw Alison Tree 💙 Amar Kishan Daniel E Spratt Albert Koong, MD PhD Pierre Blanchard, MD Sean Sachdev, MD. 🧵 coming if my kids go to 🛌 on time.

FDA Approves Erdafitinib for FGFR3+ Locally Advanced or Metastatic Urothelial Carcinoma onclive.com/view/fda-appro… via OncLive.com

Dr. Vikram M. Narayan, MD shares findings on the utility of urinary minimal residual disease in predicting recurrence of NMIBC and quantifying molecular response to nadofaragene firadenovec. #blcsm Winship Cancer Institute of Emory University Emory Urology Watch now: urologytimes.com/view/dr-naraya…

Both robotic and open superficial inguinal node dissection for cN0 penile cancer provide excellent inguinal staging with zero false negatives. See our recent two center experience.

Happy to have been able to share these important data on behalf of Society of Urologic Oncology CTC to help patients/physicians better counsel patients when evaluating treatment options for BCG unresponsive NMIBC. Emory Urologic Oncology MD Anderson Cancer Center Emory Urology 1/

Incredible work by Roger Li with truly impressive results - cretostimogene + pembrolizumab for #bcgunresponsive #NMIBC with impressive durability: 95% of CRs at 12 mos maintained at 24 mos Moffitt Cancer Center CG Oncology, Inc. Gary Steinberg